We’re designed to support emerging biopharmas

Consider the following criteria:

Operate in high-stakes commercialization phases that demand agility and speed
Require precise targeting of patients, HCPs and key stakeholders
Benefit from outsourcing expertise to complement lean teams
Keenly focused on measuring impact of media across channels to optimize performance
Prefer specialized strategic partners to maximize value instead of relying on scale from agency holding companies
Have or will need DTC/Patient activation, not just HCP media

Do these soundlike you? If so, weserve you.

You’re a brand director defending a target list everyone has an opinion about.
You’re the media lead asked to prove that half the budget is working.
You’re VP of marketing whose team of four is executing a plan sized for a company ten times larger.
You work at an independent biopharma company taking complex science to market: a mechanism the market doesn’t understand yet. With patients who don’t know they’re patients. With a prescriber universe that fits in a ballroom. You may be eighteen months from approval or eighteen months past it. Either way, the weight is specific, most of it is yours, and you shouldn’t have to explain it from scratch.

The following questions come from every launch, in almost the same words. Let us answer these questions for you. With precision.

“There are four people on my team. How does all of this actually get executed?”
Every launch task lands on the same few desks, and the plan doesn’t shrink to fit the team.
“How do I know our target list is right?”
The list is yours to defend, and everyone from sales to the C-suite has an opinion about it.
“Half the budget is media. How do I prove it’s reaching actual prescribers?”
You’ve been asked to defend numbers the data was never built to verify.

We’re giving you the readiness list we’d want in your hands before you contact anyone, including us.

How many diagnosed patients exist, and where are they concentrated? (If the answer is a prevalence estimate rather than a modeled, reachable audience, the work hasn’t started.)
What share of diagnosed patients will be enrolled in your CRM by launch day, and what’s the plan to get there? (One pre-launch team set the bar above 10% of all diagnosed patients, then raised it 20% mid-campaign because the plan was working.)
Which prescribers will write first, and is that ranking built on promotional responsiveness or last year’s deciles? (Deciles show who writes today. Responsiveness shows who moves next.)
Have your data and audience vendors been tested head to head on one yardstick, or did the best pitch win? (We’ve run four providers against each other and let the qualified-reach score decide.)
Do you know who’s actually visiting your disease education sites? (One brand assumed 100% of its HCP site visitors were HCPs. The measured number was 31%.)

Is there a ranked target list for day one, with a channel and message assigned to every tier? (Not a list of names. A sequence of moves.)
Do you know how many touches beyond the rep precede a first script for your brand? (On one launch it was 2.5 to 3. Knowing your number changes the media plan.)
Do diagnosed and undiagnosed patients see different journeys? (They want different things. One brand’s site data proved it: diagnosed patients came to manage, undiagnosed came to understand.)
Do you know which message shortens the road to a first script? (For one brand, prescribers who received samples wrote roughly three months earlier. That insight reordered the message strategy.)

Does the targeting model refresh as prescribing data accrues, and does budget actually move when it does? (A model nobody reallocates against is a report, and reports don’t bend curves.)
Can you connect media activity to prescriptions at the individual physician level? (If not, every budget defense is a story. One brand’s connected model lifted first prescriptions 10% in six months.)
What’s your media waste number, and is it shrinking? (One brand cut it 35%. You can’t shrink a number you don’t track.)

If you checked every box, you’re ahead of nearly every launch we’ve seen. If one stopped you, that box is where we work.